Comments
Loading...

ARK Genomic Revolution ETF

ARKGBATS
Logo brought to you by Benzinga Data
$26.77
0.542.06%
At Close: -
$26.88
0.110.41%
After Hours: 7:09 PM EDT
15 minutes delayed
Sector
Healthcare
Region
US
AUM
1.28B
Fund Score

ARK Genomic Revolution ETF (BATS:ARKG) Quotes, Forecast and News Summary

ARK Genomic Revolution ETF (BATS: ARKG) stock price, news, charts, stock research, profile.

Open$27.04
High$27.28
52 Wk High$34.37
AUM1.28B
Dividend-
Ex-Div Date-
Volume2.16M
Market Cap$32.24B
Mgmt Fee0.75%
P/E Ratio39.54
Prev. Close$26.23
Low$26.71
52 Wk Low$21.97
Shares Out56.50M
Yield-
Div. Freq-
Avg. Volume Daily2.63M
Beta1.50
Avg. Expense RatioNA%
P/B Ratio3.04

FAQ

Q

How do I buy ARK Genomic Revolution ETF (ARKG) stock?

A

You can purchase shares of ARK Genomic Revolution ETF (BATS:ARKG) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ARK Genomic Revolution ETF (ARKG) competitors?

A

There are no as such competitors for ARK Genomic Revolution ETF.

Q

What is the forecast, or price target, for ARK Genomic Revolution ETF (ARKG) stock?

A

There is no analysis for ARK Genomic Revolution ETF to provide a consensus price target.

Q

What is the current price for ARK Genomic Revolution ETF (ARKG)?

A

The stock price for ARK Genomic Revolution ETF (BATS: ARKG) is $26.77 last updated September 19, 2024 at 8:00 PM EDT.

Q

Does ARK Genomic Revolution ETF (ARKG) pay a dividend?

A

A quarterly cash dividend of 0.14 per share of Class A Common Stock. The quarterly cash dividend was payable on December 29, 2017 to stockholders of record on December 27, 2017.

Q

When is ARK Genomic Revolution ETF (BATS:ARKG) reporting earnings?

A

ARK Genomic Revolution ETF does not have any upcoming earnings scheduled.

Q

Is ARK Genomic Revolution ETF (ARKG) going to split?

A

There is no upcoming split for ARK Genomic Revolution ETF.

ETF Details
SectorHealthcare
CategoryMid Performer-Mid Growth
Investment StyleSmall Cap Growth
Fund InceptionOct 31, 2014
Managers
Catherine D. Wood
DefinitionMost of the stocks in this Equity Fund have average financial performance and average growth potential
Investment Policy
The Fund is an actively managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80 percent of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the Funds investment theme of the genomics* revolution (Genomics Revolution Companies). Under normal circumstances, substantially all of the Funds assets will be invested in equity securities, including common stocks, partnership interests, business trust shares and other equity investments or ownership interests in business enterprises. The Funds investments will include micro-, small-, medium- and large-capitalization companies. The Funds investments in foreign equity securities will be in both developed and emerging markets.
Top ETF Holdings
SymbolNameShare %
TWSTTwist Bioscience Corp.9.60%
CDNACaredx7.29%
SMCrispr Therapeutics Ag6.91%
RXRXRecursion Pharmaceutic...5.02%
IONSIonis Pharmaceuticals ...4.88%
NTLAIntellia Therapeutics4.74%
BEAMBeam Therapeutics Inc4.41%
SDGRSchrodinger, Inc.3.87%
ADPTAdaptive Biotechnologi...3.78%
TXG10X Genomics Inc3.61%